index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Dystrophie Musculaire de Becker BMD Skeletal muscle Muscle development Muscles/physiopathology Energy Metabolism/drug effects DMO NAD+ Activin Receptors Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS CaVβs Muscle Strength Gene modifiers L-Type Mdx mouse Knockout Dystrophy Diseases Morphogenesis Muscular Atrophy Cell homeostasis Mice Drp1 Long QT LncRNA Male Multi exon skipping Dystrophin Animals Cachexia Gene expression CD38 Cardiomyopathie Inhibitors Dynamin 2 LKB1 Liver Immunoglobulin Fc Fragments/pharmacology MiARN Cells Inbred C57BL Humans BMD Dystrophin central domain Clinical trials Multi resolution modeling Duchenne muscular dystrophy DMD Myogenesis Multiresolution modeling Muscle Becker muscular dystrophy Muscular Dystrophy Antisense oligonucleotides Cell Line Becker BMD muscular dystrophy Human Umbilical Vein Endothelial Cells Hear Dystrophin-EGFP Muscle Biology Gene Expression Regulation/drug effects LncARN Duchenne DMD dystrophy Dystrophie musculaire de Becker Animal/physiopathology Duchenne muscular dystrophy Cell Biology Allele‐specific silencing therapy Dystrophine MES DMD Génomique Calcium Mitochondrial fission Muscular dystrophy CTNNB1 Invivo Autophagy Base Sequence Epigenetics Myotendinous junction Long noncoding RNA Molecular docking Centronuclear myopathy Ex-vivo Calcium Channels Becker muscular dystrophy BMD Homeostasis CaV subunits Delivery Dystrophie Musculaire de Duchenne DMD NNOS Cultured Inbred mdx Hepatocellular carcinoma Modificateurs de gènes DHPR α1S Exon skipping Molecular Sequence Data Genomic Cardiomyopathy Metabolism